Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma.
作者信息
Manasanch Elisabet E, Braylan Raul, Stetler-Stevenson Maryalice, Yuan Constance, Gounden Verena, Korde Neha, Tageja Nishant, Bhutani Manisha, Calvo Katherine, Maric Irina, Roschewski Mark, Staudt Louis M, Landgren Ola
机构信息
Multiple Myeloma Section.
出版信息
Leuk Lymphoma. 2014 Jun;55(6):1402-3. doi: 10.3109/10428194.2013.831091. Epub 2013 Dec 2.
Abstract
摘要
相似文献
1
Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma.
Leuk Lymphoma. 2014 Jun;55(6):1402-3. doi: 10.3109/10428194.2013.831091. Epub 2013 Dec 2.
2
Significances of MYD88 and CXCR4 Mutations in Waldenstrom Macroglobulinemia.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017 Aug 20;39(4):578-582. doi: 10.3881/j.issn.1000-503X.2017.04.019.
3
Highly sensitive mutation detection by droplet digital polymerase chain reaction in Waldenström macroglobulinemia.
Haematologica. 2018 Jun;103(6):1029-1037. doi: 10.3324/haematol.2017.186528. Epub 2018 Mar 22.
4
Response to ibrutinib in a patient with IgG lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation.
Leuk Lymphoma. 2016 Nov;57(11):2699-701. doi: 10.3109/10428194.2016.1157875. Epub 2016 Mar 16.
5
An unusual case of cutaneous Waldenström macroglobulinemia with the MYD88 L265P mutation.
J Cutan Pathol. 2020 Sep;47(9):850-853. doi: 10.1111/cup.13722. Epub 2020 Jul 17.
6
Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations.
Am J Clin Pathol. 2016 Jun;145(6):843-51. doi: 10.1093/ajcp/aqw072. Epub 2016 Jun 21.
7
[The clinical features of patients with lymphoplasmacytic diseases harboring MyD88 L265P mutation].
Zhonghua Xue Ye Xue Za Zhi. 2016 Dec 14;37(12):1054-1059. doi: 10.3760/cma.j.issn.0253-2727.2016.12.009.
8
IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house.
Ann Hematol. 2014 Sep;93(9):1605-7. doi: 10.1007/s00277-013-2004-x. Epub 2014 Jan 10.
9
[Successful diagnosis of lymphoplasmacytic lymphoma with IgG paraprotein using MYD88 L265P mutation analysis].
Rinsho Ketsueki. 2018;59(6):695-697. doi: 10.11406/rinketsu.59.695.
10
MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.
Blood. 2013 Mar 14;121(11):2051-8. doi: 10.1182/blood-2012-09-454355. Epub 2013 Jan 15.
引用本文的文献
1
Lymphoplasmacytic lymphoma and marginal zone lymphoma involving bone marrow: A diagnostic dilemma. Useful clinicopathological features to accurate the diagnosis.
EJHaem. 2022 Oct 5;3(4):1181-1187. doi: 10.1002/jha2.573. eCollection 2022 Nov.
2
MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.
Mod Pathol. 2015 Apr;28(4):564-74. doi: 10.1038/modpathol.2014.120. Epub 2014 Sep 12.
3
Clonotypic analysis of immunoglobulin heavy chain sequences in patients with Waldenström's macroglobulinemia: correlation with MYD88 L265P somatic mutation status, clinical features, and outcome.
Biomed Res Int. 2014;2014:809103. doi: 10.1155/2014/809103. Epub 2014 Aug 14.
本文引用的文献
1
Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms.
Blood. 2013 Mar 28;121(13):2522-8. doi: 10.1182/blood-2012-09-457101. Epub 2013 Jan 25.
2
MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.
Blood. 2013 Mar 14;121(11):2051-8. doi: 10.1182/blood-2012-09-454355. Epub 2013 Jan 15.
3
MYD88 L265P somatic mutation in IgM MGUS.
N Engl J Med. 2012 Dec 6;367(23):2255-6; author reply 2256-7. doi: 10.1056/NEJMc1211959.
4
MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
N Engl J Med. 2012 Aug 30;367(9):826-33. doi: 10.1056/NEJMoa1200710.
5
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies.
Blood. 2011 May 26;117(21):5573-81. doi: 10.1182/blood-2011-01-270140. Epub 2011 Mar 25.
6
Oncogenically active MYD88 mutations in human lymphoma.
Nature. 2011 Feb 3;470(7332):115-9. doi: 10.1038/nature09671. Epub 2010 Dec 22.
Zotero 插件